No. CS/CS/HB 309
Filed under Criminal Justice.
Controlled Substances; Excepts from list of Schedule I controlled substances certain xylazine animal drug products approved by United States Food & Drug Administration & used for certain purposes; provides criminal penalties & requires mandatory minimum term of imprisonment if person sells, manufactures, or delivers or possesses with intent to sell, manufacture, or deliver xylazine; creates offense of trafficking in xylazine; provides criminal penalties & requires mandatory minimum term of imprisonment & fines based on quantity of controlled substance involved in offense.
Plain English Summary
AI-GENERATEDXylazine remains a Schedule I controlled substance, but FDA-approved animal drug products are now exempt from that classification.
Selling, manufacturing, or possessing with intent to sell xylazine carries new criminal penalties and mandatory minimum prison terms.
A new first-degree felony, "trafficking in xylazine," is created for possessing 28 grams or more of the substance.
Mandatory minimum sentences range from 3 to 25 years, with fines up to $500,000, based on the quantity involved.
AIRemoves FDA-approved veterinary xylazine from Schedule I control
AIExplicitly excludes human use from the veterinary exception, keeping it fully controlled
AIAdds xylazine to the list of substances triggering enhanced penalties for fentanyl analog offenses
AICreates a new first-degree felony for trafficking 28+ grams of xylazine with mandatory minimums